When do you know it’s time to ‘buy the dip’? You could be catching a falling knife
Nick Sundich, July 12, 2024
‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases, investor can make money by taking advantage of buying a company at a lower price.
Theoretically, this is a good way to make money, but it is also a very risky way because a company’s share price might keep going down. So, how can you tell when it really is time to buy the dip?
Why a company might be sold off
A stock can be sold off for four reasons:
1. Short-term fears
2. Short term realities that will resolve themselves
3. Short-term realities that need management intervention
4. Long-term vulnerability of the business model
To put it simply, there is a good chance that a ‘buy the dip’ strategy might work in the first scenario and maybe in the second, but not in the latter two.
When it is time to buy a dip
Let’s look at the first of these scenarios first. Investors can sometimes have fears about a company that may be legitimate but are not a reality. Money can be made from a ‘buy the dip’ strategy when investors realise the fears are not illegitimate.
The most pertinent example of this in recent times is retail stocks that are perceived to be discretionary. Investors fear that customers will cut back their spending on these goods or services. Such companies having included casual fashion outlet Universal Store (ASX:UNI) and Breville (ASX:BRG). Many of these companies’ sales have actually held up regardless.
Of course, not all discretionary retailers are holding up – in fact, many are struggling. So the money is made by finding companies that are outperforming their peers.
When it may or may not be time to buy the dip
When stocks are sold off due to realities, it is unlikely to be time to ‘buy the dip’ unless the issues are short-term and are likely to resolve themselves quickly without intervention by the management. An example of this is Medibank (ASX:MPL) in the aftermath of its cyberattack.
Don’t get us wrong, this was a serious incident that will keep the company bearing financial and reputational scars for some time. However, it is unlikely that a cyberattack will happen again and that there’ll be an en-masse outflow of members.
When it certainly isn’t time to buy the dip
When stocks are sold off due to realities that will need intervention from the management, the stock is unlikely to recover until they are resolved. These can be short or long term issues. A hypothetical example would be a medical device company having regulatory approval in its key market withdrawn.
The opportunity to ‘buy the dip’ might appear bigger, just because of the size of the decline. But it is unlikely the stock will recover unless in that instance approval is regained or if an alternative market is found that makes up for the one that is lost.
Don’t catch a falling knife
Adopting a ‘buy the dip’ strategy and suffering losses is often described as ‘catching a falling knife’, metaphorical for the pain of losses. Investors adopting a buy the dip strategy need to be careful. A stock may well be sold off for wrong reasons, but there is a fine line between the literal wrong reasons and reasons you disagree with.
Furthermore, for the stock to recover it will require one of two things. First, the investors that sold off the company that will need to regain their faith in it and buy again. Or second, new investors to discover the company, realise what a gem it is and invest in it.
Either way, the money is made by you getting in before either happens (if indeed it does).
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years
If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…
Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017
Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…
CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know
In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…